Understanding antibody-dependent enhancement in dengue: Are afucosylated IgG1s a concern?

Teo, Andrew; Tan, Hao Dong; Loy, Thomas; Chia, Po Ying; Chua, Caroline Lin Lin

Teo, Andrew; Tan, Hao Dong; Loy, Thomas; Chia, Po Ying; Chua, Caroline Lin Lin.

Afiliação

Teo A; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
Tan HD; National Centre for Infectious Diseases, Singapore, Singapore.
Loy T; Department of Medicine, The Doherty Institute, University of Melbourne, Melbourne, Australia.
Chia PY; School of Biosciences, Faculty of Health and Medicine Sciences, Taylor's University, Subang Jaya, Malaysia.
Chua CLL; A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.

PLoS Pathog ; 19(3): e1011223, 2023 03.

Article em En | MEDLINE | ID: mdl-36996026

Assuntos

Anticorpos Facilitadores; Dengue; Humanos; Anticorpos Antivirais

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Facilitadores / Dengue Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google